We Achieved ISO Certification! Now What?

Global Medical Device Podcast · 17 Nov 2022 · 43m · Episode 290

What this episode covers

Mark Alpert, Director of Quality at Greenlight Guru, explains that achieving ISO 9001 and ISO 27001 certification is merely the beginning of the journey, not the destination. He argues that companies must align their Quality Management System (QMS) with their broader business strategy to drive continuous improvement and use quality as a competitive advantage. Alpert highlights the common pitfall of focusing only on reactive Corrective Actions (CAPA) rather than proactive process improvement, urging leaders to create strategic gaps to drive performance. He emphasizes that a mature QMS integrates all functions, from sales to finance, to ensure the entire organization works toward the same high-level goals.

Mentioned

Companies
Greenlight Guru, TUV SUD America
Also
ISO 9001, ISO 27001, ISO 13485, FDA

Other shows on the same ground, closest first.

  • The Manufacturing Executive · 29m

    Digitizing Quality Management

    Andrew Steele, founder of FactoryQA, discusses the critical role of quality management systems (QMS) in manufacturing, emphasizing that quality must be a cultural element driven by engaged employees rather than just a posted policy. He explains how ISO 9001 certification serves as a vital credibility signal for suppliers and outlines the significant risks of poor quality, including high costs of poor quality and reputational damage. Steele highlights the inefficiencies of analog, paper-based systems and introduces FactoryQA as a cloud-based solution that digitizes non-conformance tracking, document control, and inspection sheets to enable real-time analytics and predictive maintenance.

  • Let's Combinate · 30m

    100 - PQMCoach, Our First Recording, Quality (Big Q/little q), Why Predictive Quality Management, and Communicating Quality with Larry Mager

    Larry Mager, Principal at Mgmt-Ctrl and founder of PQMCoach.com, discusses his evolution from a Fortune 500 quality engineer to a startup operator who built a Quality Management System (QMS) from scratch for a cardiovascular device. He explains the shift from 'Big Q' compliance to 'Little Q' operational excellence, detailing how he navigated an FDA consent decree at a large manufacturer and later moved into consulting to address communication barriers in quality management. Mager advocates for Predictive Quality Management (PQM) and the Plan-Do-Check-Act (PDCA) cycle as universal tools for improving business performance across pharma, medical devices, and CROs.

  • Let's Combinate · 35m

    205 - Why Less Than 20% of Companies Have Started Quality 4.0

    Larry Mager, Founder of MGMT-CTRL, explains why fewer than 20% of companies have started Quality 4.0 despite 63% believing it will transform operations. He introduces his Quantum Quality Management (QQM) framework, a five-phase roadmap that prioritizes people, process, and technology to move beyond compliance. Mager argues that legacy Electronic Quality Management Systems (EQMS) fail because they are pre-programmed, whereas modern solutions use 'digital twins' to model workflows and ensure digital continuity. He emphasizes that successful implementation requires a strategic roadmap, cultural change, and management control rather than just installing software.

  • Let's Combinate · 48m

    127 - BIG Risk Management Changes in QMSR, Risk Acceptability, Risk Policy & Explaining vs. Justifying Risk Decisions with Naveen Aggarwal

    Naveen Aggarwal, founder of Creative Analytic Solutions, explains that the QMSR final rule does not mandate ISO 14971 but requires risk management to be integrated into ISO 13485 quality systems, shifting FDA inspection focus from procedural compliance to risk-based decision-making. He highlights that small and mid-size companies face significant costs to transition, while large firms must overcome the challenge of linking risk outputs to design inputs and post-market data. Aggarwal advises against standalone risk policies, suggesting instead that companies integrate risk acceptability criteria into their existing quality policies and use clear, binary (red/green) risk matrices rather than ambiguous yellow zones.

  • Let's Combinate · 8m

    237 - ICH Q10: The Pharmaceutical Quality System

    Subhi Saadeh, founder of Let’s Combinate, explains the ICH Q10 guideline on the Pharmaceutical Quality System (PQS), distinguishing it from certifiable standards like ISO 9001 and ISO 13485. He details how PQS augments regional GMPs across the product lifecycle, emphasizing phase-appropriate controls and management responsibility for outsourced activities. The episode covers the four core PQS elements—process performance monitoring, CAPA, change management, and management review—and their role in continual improvement.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.